Lentiviral vector-mediated gene therapy of hepatocytes ex vivo for autologous transplantation in swine

Robert A. Kaiser, Shennen A. Mao, Jaime Glorioso, Bruce Amiot, Clara T. Nicolas, Kari L. Allen, Zeji Du, Caitlin J. Vanlith, D. Hickey, Scott L. Nyberg, Joseph B. Lillegard

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Gene therapy is an ideal choice to cure many inborn errors of metabolism of the liver. Ex-vivo, lentiviral vectors have been used successfully in the treatment of many hematopoietic diseases in humans, as their use offers stable transgene expression due to the vector's ability to integrate into the host genome. This method demonstrates the application of ex vivo gene therapy of hepatocytes to a large animal model of hereditary tyrosinemia type I. This process consists of 1) isolation of primary hepatocytes from the autologous donor/recipient animal, 2) ex vivo gene delivery via hepatocyte transduction with a lentiviral vector, and 3) autologous transplant of corrected hepatocytes via portal vein injection. Success of the method generally relies upon efficient and sterile removal of the liver resection, careful handling of the excised specimen for isolation of viable hepatocytes sufficient for re-engrafting, high-percentage transduction of the isolated cells, and aseptic surgical procedures throughout to prevent infection. Technical failure at any of these steps will result in low yield of viable transduced hepatocytes for autologous transplant or infection of the donor/recipient animal. The pig model of human type 1 hereditary tyrosinemia (HT-1) chosen for this approach is uniquely amenable to such a method, as even a small percentage of engraftment of corrected cells will lead to repopulation of the liver with healthy cells based on a powerful selective advantage over native-diseased hepatocytes. Although this growth selection will not be true for all indications, this approach is a foundation for expansion into other indications and allows for manipulation of this environment to address additional diseases, both within the liver and beyond, while controlling for exposure to viral vector and opportunity for off-target toxicity and tumorigenicity.

Original languageEnglish (US)
Article numbere58399
JournalJournal of Visualized Experiments
Issue number141
StatePublished - 2018


  • Autologous Transplantation
  • Gene Therapy
  • Hepatocyte Isolation
  • Inborn Errors of Metabolism
  • Issue 141
  • Lentiviral Vector
  • Medicine
  • Pig Surgical model

ASJC Scopus subject areas

  • General Neuroscience
  • General Chemical Engineering
  • General Biochemistry, Genetics and Molecular Biology
  • General Immunology and Microbiology


Dive into the research topics of 'Lentiviral vector-mediated gene therapy of hepatocytes ex vivo for autologous transplantation in swine'. Together they form a unique fingerprint.

Cite this